<div class="container">

<table style="width: 100%;"><tr>
<td>ex6_crossing</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Time-to-event data example 6 for non-proportional hazards working group</h2>

<h3>Description</h3>

<p>Survival objects reverse-engineered datasets from published Kaplan-Meier
curves.
Individual trials are de-identified since the data are only
approximations of the actual data.
Data are intended to evaluate methods and designs for trials where
non-proportional hazards may be anticipated for outcome data.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(ex6_crossing)
</code></pre>


<h3>Format</h3>

<p>Data frame with 4 variables:
</p>

<ul>
<li> <p><code>id</code>: Sequential numbering of unique identifiers.
</p>
</li>
<li> <p><code>month</code>: Time-to-event.
</p>
</li>
<li> <p><code>event</code>: 1 for event, 0 for censored.
</p>
</li>
<li> <p><code>trt</code>: 1 for experimental, 0 for control.
</p>
</li>
</ul>
<h3>References</h3>

<p>Lin, Ray S., Ji Lin, Satrajit Roychoudhury, Keaven M. Anderson, Tianle Hu,
Bo Huang, Larry F Leon, Jason J.Z. Liao, Rong Liu, Xiaodong Luo,
Pralay Mukhopadhyay, Rui Qin, Kay Tatsuoka, Xuejing Wang,
Yang Wang, Jian Zhu, Tai-Tsang Chen, Renee Iacona &amp;
Cross-Pharma Non-proportional Hazards Working Group. 2020.
Alternative analysis methods for time to event endpoints under
nonproportional hazards: A comparative analysis.
<em>Statistics in Biopharmaceutical Research</em> 12(2): 187â€“198.
</p>


<h3>See Also</h3>

<p>ex1_delayed_effect,
ex2_delayed_effect,
ex3_cure_with_ph,
ex4_belly,
ex5_widening
</p>


<h3>Examples</h3>

<pre><code class="language-R">library(survival)

data(ex6_crossing)
km1 &lt;- with(ex6_crossing, survfit(Surv(month, evntd) ~ trt))
km1
plot(km1)
</code></pre>


</div>